Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
Comments Off on Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation.
April 27, 2026
A new preclinical study demonstrates that CBD glioblastoma prevention may be possible through extended pretreatment in mice. While promising, this early research requires extensive human studies before any clinical applications. Dr. Caplan explains what…
Exploring CBD as a Prophylactic Agent Against Glioblastoma Growth
Comments Off on Exploring CBD as a Prophylactic Agent Against Glioblastoma Growth
March 25, 2026
This CBD glioblastoma preclinical study examines cannabidiol's potential to reduce tumor growth in glioblastoma. The research shows prolonged CBD exposure may modulate immune and tumor markers. While promising, these findings are preliminary and require…